Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
5.77
Dollar change
-0.16
Percentage change
-2.70
%
IndexRUT P/E- EPS (ttm)-1.65 Insider Own17.10% Shs Outstand141.59M Perf Week6.56%
Market Cap1.46B Forward P/E- EPS next Y-0.06 Insider Trans0.45% Shs Float117.59M Perf Month-0.17%
Income-224.66M PEG- EPS next Q-0.04 Inst Own89.86% Short Float6.72% Perf Quarter-32.98%
Sales276.92M P/S5.26 EPS this Y-368.29% Inst Trans-1.74% Short Ratio4.35 Perf Half Y-26.78%
Book/sh2.44 P/B2.37 EPS next Y26.50% ROA-12.67% Short Interest7.90M Perf Year12.04%
Cash/sh2.29 P/C2.52 EPS next 5Y2.77% ROE-51.98% 52W Range4.28 - 11.56 Perf YTD-11.91%
Dividend Est.- P/FCF- EPS past 5Y-37.53% ROI-25.16% 52W High-50.06% Beta-0.08
Dividend TTM- Quick Ratio9.94 Sales past 5Y47.72% Gross Margin38.69% 52W Low34.97% ATR (14)0.47
Dividend Ex-Date- Current Ratio10.74 EPS Y/Y TTM-982.55% Oper. Margin-14.86% RSI (14)49.07 Volatility7.90% 8.75%
Employees650 Debt/Eq1.63 Sales Y/Y TTM-33.99% Profit Margin-81.13% Recom2.07 Target Price8.98
Option/ShortYes / Yes LT Debt/Eq1.59 EPS Q/Q-1327.76% Payout- Rel Volume0.74 Prev Close5.93
Sales Surprise-3.49% EPS Surprise-138.10% Sales Q/Q-2.49% EarningsNov 07 AMC Avg Volume1.82M Price5.77
SMA209.12% SMA50-13.13% SMA200-28.37% Trades Volume1,343,716 Change-2.70%
Date Action Analyst Rating Change Price Target Change
Dec-05-24Downgrade Goldman Neutral → Sell $4.25
Nov-14-24Initiated Wolfe Research Peer Perform
Nov-08-24Downgrade William Blair Outperform → Mkt Perform
Aug-28-24Initiated Wells Fargo Overweight $10
Aug-13-24Downgrade Morgan Stanley Overweight → Equal-Weight $11 → $10
Apr-10-24Initiated Craig Hallum Buy $15
Dec-12-23Upgrade BofA Securities Neutral → Buy $10 → $8
Aug-08-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-23-23Downgrade Credit Suisse Outperform → Neutral $18 → $14
May-09-23Downgrade Goldman Buy → Neutral
Dec-05-24 04:05PM
Nov-12-24 08:05AM
Nov-09-24 06:51AM
Nov-08-24 02:20PM
03:15AM
02:34AM Loading…
02:34AM
Nov-07-24 04:01PM
04:01PM
Oct-15-24 04:05PM
Oct-09-24 08:03AM
Sep-24-24 08:12AM
Aug-28-24 07:49AM
Aug-12-24 08:05AM
Aug-08-24 12:45AM
Aug-07-24 04:05PM
04:05PM Loading…
Jul-29-24 04:05PM
Jul-10-24 08:00AM
Jul-02-24 04:00PM
Jun-20-24 09:15AM
Jun-17-24 09:54AM
Jun-12-24 02:38AM
May-17-24 11:52AM
May-13-24 08:00AM
May-09-24 04:18PM
04:05PM
10:53AM
10:11AM
04:02AM
03:15AM
May-08-24 08:57PM
04:05PM Loading…
04:05PM
Apr-30-24 07:31AM
Apr-18-24 07:36AM
Apr-10-24 04:05PM
Mar-28-24 04:00PM
Mar-19-24 07:48AM
Mar-12-24 04:15PM
Feb-23-24 12:15PM
10:10AM
Feb-22-24 08:30PM
04:43PM
04:05PM
Feb-21-24 08:00AM
Feb-13-24 08:30AM
Feb-11-24 05:00PM
Feb-07-24 06:46AM
Jan-29-24 08:00AM
Dec-18-23 05:27AM
Nov-24-23 08:39AM
Nov-09-23 08:15AM
Nov-08-23 04:02PM
12:00AM
Nov-07-23 04:49PM
04:05PM
Nov-02-23 06:47AM
Oct-20-23 12:08PM
Oct-17-23 08:15AM
Sep-29-23 12:43PM
08:15AM
Sep-25-23 08:49AM
Sep-19-23 09:31AM
Sep-05-23 04:15PM
Aug-23-23 08:15AM
Aug-22-23 08:14AM
Aug-09-23 04:15PM
06:03AM
Aug-08-23 06:20AM
01:30AM
Aug-07-23 04:05PM
Jul-27-23 04:05PM
Jul-24-23 04:05PM
Jul-20-23 04:05PM
Jul-18-23 08:37AM
Jul-16-23 08:51AM
Jun-06-23 08:00AM
May-24-23 08:10AM
May-09-23 12:49PM
08:00AM
01:00AM
May-08-23 05:35PM
04:05PM
Apr-17-23 04:15PM
Mar-28-23 05:00PM
Mar-20-23 06:50AM
Mar-13-23 08:45AM
Mar-09-23 06:40AM
Mar-08-23 08:00AM
Mar-04-23 08:19AM
Mar-02-23 08:45AM
Feb-27-23 05:35AM
Feb-23-23 01:00AM
Feb-22-23 05:55PM
04:05PM
Feb-16-23 10:01AM
Feb-15-23 10:00AM
Feb-14-23 04:33PM
Feb-07-23 10:15AM
Feb-06-23 07:34AM
Feb-01-23 08:00AM
Jan-27-23 09:37AM
Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeFord John ADirectorNov 12 '24Buy5.7517,500100,62570,046Nov 14 04:32 PM
HULL CARLSee RemarksNov 11 '24Buy5.64175,000987,000175,000Nov 12 04:59 PM
GTCR INVESTMENT XI LLCDirectorMay 28 '24Sale9.819,940,97497,570,66020,150,005May 30 05:39 PM